Cognitive effects of intravenous Ketamine in treatment-resistant depression: A systematic review.
Psychological Medicine May 8, 2026 Lou-Anne Chavigny, Véronique Desbeaumes Jodoin, Nicolas Garel et al.
Intravenous (IV) low-dose ketamine has emerged as a promising treatment for patients with treatment-resistant depression (TRD). However, its impact on cognitive functioning remains unclear. This systematic review examines the cognitive and executive effects of IV ketamine in TRD, focusing on their relationship to depressive and suicidal outcomes. A systematic search of Cochrane, MEDLINE,...